UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~ 30June 20, 2006

LARGE SCALE BIOLOGY CORPORATION

(Exact name of Registrant as specified in its charter)

Delaware		000-31275		77-0154648
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3333 Vaca Valley Parkway, Vacaville, California 95688

(Address of principal executive offices and zip code)

(707) 446-5501

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 8.01—OTHER EVENTS.

~~Large~~On June 19, 2006, Large Scale Biology Corporation, and certain of its subsidiaries, including Large Scale Bioprocessing Inc. and Predictive Diagnostics Inc., ~~are~~filed ~~required to~~a ~~file~~First ~~monthly~~Amended ~~operating~~Disclosure ~~reports~~Statement ~~with~~ (the “Disclosure ~~Office~~Statement”) and First Amended Joint Plan of Liquidation (the “Plan”) with the United States ~~Trustee~~ Bankruptcy Court for the Eastern District of California (the “USCourt”). ~~Trustee~~On June 20, 2006, the Court filed an order (the “Order”) ~~pursuant~~(1) approving tothe Disclosure Statement, (2) fixing July 20, 2006 as the USlast day ~~Trustee’s~~ for filing ~~Operating~~written ~~Guidelines~~acceptances or rejections of the Plan, (3) ordering that on or before June 26, 2006, the Plan, the Disclosure Statement and ~~Financial~~a ~~Reporting~~ballot ~~Requirements~~shall be mailed ~~for~~to creditors, equity security holders and other parties in interest, ~~Chapter~~ (4) fixing July 31, 2006 at 11:00 ~~cases~~a.m. Inas ~~connection~~the ~~therewith~~date and time for the hearing regarding confirmation of the Plan and (5) fixing July 24, 2006 as the last day for filing and serving written objections to confirmation of the Plan. A copy of the Plan is attached hereto as Exhibit 99 2.1, ~~are~~and ~~the~~is ~~monthly~~incorporated ~~operating~~herein ~~reports~~by reference. ~~that~~Copies of the ~~Company~~Disclosure Statement and the ~~Subsidiaries~~ ~~filed~~Order ~~with~~are ~~the~~attached ~~Court~~hereto as ~~for~~Exhibits ~~the~~99.1 ~~period~~and ~~ended~~99.2, ~~April~~respectively ~~30,~~and ~~2006.~~are incorporated herein by reference.

~~Documents~~The Disclosure Statement, Plan, Order, ballot and other documents filed with the Court in connection with the ~~Agreement~~bankruptcy (other than documents filed under seal or otherwise subject to confidentiality protections) may be accessed by going to the webpage established by the Corporation’s bankruptcy counsel, www.ffwplaw.com, and clicking on the “Cases” link, and then clicking on the “Large Scale Biology Corporation” case link. The information set forth on the foregoing website shall not be deemed to be a part of or incorporated by reference into this Form 8-K.

ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS.

(d)

Exhibits.

992.1 ~~Large~~Debtors’ ~~Scale~~First ~~Biology~~Amended ~~Corporation,~~Joint ~~Large~~Plan ~~Scale~~of ~~Bioprocessing Inc. and Predictive Diagnostics Inc. - Chapter 11 Monthly Operating Report to the US Trustee for the period ended April 30, 2006.~~Liquidation

99.1

First Amended Disclosure Statement to Debtors’ First Amended Joint Plan of Liquidation

99.2

Order Approving First Amended Disclosure Statement and Fixing Time for Filing Objections and Acceptances or Rejections of Plan, Combined with Notice Thereof.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Large Scale Biology Corporation
Date: May 30, 2006	By:	/s/ Robert L. Erwin
Date: June 26, 2006	By:	/s/ Robert L. Erwin
		Robert L. Erwin, Chairman of the Board

Filing Compare · LARGE SCALE BIOLOGY CORP